Sonar Launches SonarQube 9.9 LTS to Help Organizations Achieve a State of Clean Code
7.2.2023 14:00:00 EET | Business Wire | Press release
SonarSource, the leading provider of Clean Code solution, today launched SonarQube 9.9 Long-Term Support (LTS). The new release empowers organizations to achieve the Clean Code state quickly, securely, and at scale. With accelerated pull request analysis, support for building and deploying secure cloud-native applications, sophisticated enterprise-grade capabilities, and many innovations related to the detection engine and contextual education, SonarQube 9.9 LTS supercharges organizations to deliver new business value and keep their software a long-term asset.
“Sonar has greatly helped us benchmark and standardize the quality of our codebase - and the LTS makes it much easier for us to deliver Clean Code. The integration with Azure DevOps from a project-to-project perspective as well as the token lifecycle management will be greatly appreciated by our admins and will help streamline our process,” said Stefan Euripidou, Enterprise Architect for DevOps and CICD at Vodafone Group.
Clean Code is essential for every organization competing in today’s digital-driven economy. Poor quality software costs businesses over $2 trillion a year in the US alone, hampering service quality, brand reputation, worker productivity, and employee retention. Code is the difference between good and bad software. Sonar’s latest 9.9 LTS release introduces key capabilities to enable enterprises to build better software in a sustained manner.
“Our mission is to equip organizations with the solution and methodology to achieve a state of Clean Code, making all code fit for development and production. When companies embrace Clean Code practices, they can derive more from their software, minimize risks, and ensure that their software continues to stay valuable,” said Olivier Gaudin, Founder and CEO of SonarSource. “SonarQube 9.9 LTS was designed to not only provide immediate value to our users for their current development but to steadily drive organizations toward a state of Clean Code in a way that’s predictable, reliable, and sustainable.”
Key release innovations
Pull Request Analyzed in Minutes
SonarQube 9.9 LTS provides a significant speed boost for Pull Request (PR) analysis. PRs are now analyzed more than twice as fast, while still providing the same high-precision results. With the implementation of incremental analysis and server-side caching, analysis is more efficient. As developers write and commit code, Pull Request analysis is an important step in merging new code changes to the main branch. Faster analysis means a more efficient software development lifecycle, as developers spend less time waiting and more time delivering business critical features.
Secure Cloud Native Applications
As applications move to the cloud, organizations must ensure the security of not only the source code, but also their configuration files and deployments. SonarQube 9.9 LTS delivers in-depth analysis capabilities to detect ‘secrets’ in code, bad practices, and vulnerabilities so that developers can build and deploy secure cloud native applications. The release adds support for major cloud providers – AWS, Google Cloud, Microsoft Azure, and their underlying technologies – serverless and SAM frameworks, AWS Cloud Development Kit, Infrastructure-as-Code tools (Terraform and Cloudformation), and containerization tools with Kubernetes and Docker. With these additions, organizations can be sure that their cloud native apps are as secure as their traditional on-prem apps.
Enterprise-grade features for Coding at Scale
SonarQube 9.9 LTS introduces stronger access management, administration, governance, and reporting capabilities, enabling organizations to better manage the security and administration of their SonarQube instance and their portfolio of code assets. Chief among these new features are advanced security and compliance reporting, project and portfolio reporting, secure token handling, SCIM integration for user management, and more. Customers using the Data Center Edition can now deploy SonarQube clusters with Kubernetes. Together, these reporting, authentication and operational improvements make it easier to use, secure, and manage SonarQube instances than ever before.
“The latest SonarQube release introduces a variety of critical new features. Not only will we benefit from the new Terraform scan support, but we will also use the enhanced reporting and administration capabilities to strengthen our Quality Gates and streamline communication efforts,” said Vojtech Varga, Service Manager at Siemens AG. “Sonar’s LTS is an opportunity for us to access the latest fixes and features to ensure that we continue to operate with the highest-quality code.”
Increased Detection of all Issue Types; Rich Educational Guidance
Continued innovation in the detection engine allows for improved precision, speed, accuracy, and coverage of all issue types. Users can find and fix more issues in their code. And this LTS release brings in rich educational content to make taint analysis rules easy to understand and contextual to the users’ code and framework – continuing the advancement of the company’s education initiative.
Clean as You Code, the Sustainable Approach to Clean Code
Sonar is a strong proponent of deploying compliant quality gates that will progressively drive organizations to reach a state of Clean Code. This LTS release adds enhancements to the quality gate user experience to help everyone implement and practice Clean as You Code. Quality gates that are not compliant with this methodology can be easily identified and updated.
SonarQube 9.9 LTS is now available for everyone. Read more in the full release announcement and download the LTS for your edition here.
About SonarSource
Sonar empowers developers and organizations to systematically achieve a state of Clean Code so that all code is fit for development and production. By applying the Sonar Clean as You Code methodology, organizations minimize risk, reduce technical debt, and derive more value from their software in a predictable and sustainable way.
The open source and commercial Sonar solution – SonarLint, SonarCloud, and SonarQube – supports over 30 programming languages, frameworks, and infrastructure technologies. Trusted by more than 400,000 organizations globally to clean more than half a trillion lines of code, Sonar is integral to delivering better software.
To learn more about SonarSource, please visit https://www.sonarsource.com/company/about/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230207005514/en/
Contact information
Media Contact
Jordan Tewell
10Fold for SonarSource
415-666-6066
sonarsource@10fold.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CorFlow Therapeutics Announces Successful Completion of Phase 1 and First Patients Enrolled in Phase 2 of the MOCA II Pivotal Trial, Approval to Start the REVITALISE RCT in Europe, and Strengthening of Clinical Leadership30.4.2026 14:00:00 EEST | Press release
CorFlow Therapeutics AG (CorFlow), a clinical-stage company focused on transforming the diagnosis and treatment for heart attack patients, today announced multiple milestones in advancing its clinical program and the strengthening of clinical leadership. Phase 1 of the company’s MOCA II FDA Pivotal Trial was successfully reached after safety and performance goals were met with STEMI heart attack patients who had the proprietary PCoFI diagnostic measurement of microvascular obstruction (MVO) made during a stenting procedure, when compared to the reference standard diagnosis by cardiac MRI in the subsequent days. Phase 1 included 19 patients enrolled across 5 US and 3 European sites. MOCA II follows the FIH MOCA I study and primarily aims to validate the threshold value of the proprietary PCoFI measurement for diagnosing MVO in the setting of primary angioplasty compared to cardiac MRI. This milestone achievement, which was confirmed by the study’s independent DSMB (Data and Safety Monit
Agendia to Present New Data Demonstrating the Expanded Clinical Utility of MammaPrint ® and BluePrint ® at the 2026 ESMO Breast Cancer Annual Congress30.4.2026 14:00:00 EEST | Press release
Agendia®, Inc., a leader in precision oncology for breast cancer, today announced it will present new data at the 2026 European Society for Medical Oncology (ESMO) Annual Congress on Breast Cancer, taking place May 6-8 in Berlin, Germany. The company will present two posters featuring data from the prospective FLEX Study and an independent post hoc analysis of the landmark MINDACT trial that underscore the prognostic value of MammaPrint® + BluePrint® in early-stage breast cancer (EBC). Poster #65P | Thursday, May 7, 13:15 – 14:15 p.m. CEST | Presenter: Elena Shagisultanova Prognostic Performance of MammaPrint in Patients with Small T1a, b, and c Node-Negative Early Breast Cancer A retrospective analysis from the FLEX Study involving 4,349 patients highlights the biological heterogeneity within small, node-negative (T1a, b, and c) tumors – a group that typically has favorable outcomes. MammaPrint (MP) identified a High Risk 2 (H2) subset, representing 10% of all patients and 5% of those
The Biggest Predictor of Business Growth Is Behavior30.4.2026 10:00:00 EEST | Press release
IDEO, the global design and innovation company, today announced the IDEO Innovation Quotient (IDEO IQ), a new report measuring how workplace behaviors drive business performance across 100 of the world’s largest companies. Those with the highest IDEO IQ scores earned nearly $20 billion in profit last year—50% higher than average and three times more than those ranked at the bottom. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429978890/en/ The IDEO Innovation Quotient (IDEO IQ) is a new report measuring how workplace behaviors drive business performance across 100 of the world’s largest companies. The IDEO IQ surveyed 266 leaders in product and innovation roles at 100 of the world’s largest companies across the Media & Technology, Healthcare, and Consumer Goods sectors. The report is the first of its kind to draw a direct line between how companies operate internally and their financial performance. Companies were surve
Suzano Sells 12.7 Million Tonnes of Pulp for the First Time in Its History30.4.2026 01:22:00 EEST | Press release
Suzano(B3: SUZB3 | NYSE: SUZ), the world’s largest pulp producer, announces its results for the first quarter of 2026 (1Q26), achieving a new all‑time record in pulp sales. Over the 12‑month period from April 2025 to March 2026, the company sold 12.7 million tonnes of pulp, the highest volume ever recorded in its history. During the same period, Suzano also sold 1.7 million tonnes of paper across the packaging, printing and writing, specialty, and tissue segments. This unprecedented sales level mainly reflects the increase in production capacity following the start‑up of the Ribas do Rio Pardo pulp mill in the state of Mato Grosso do Sul, as well as Suzano’s strong operational efficiency across its production lines and supply chains, serving customers in more than 100 countries worldwide. In the first quarter of 2026, Suzano sold a total of 3.2 million tonnes, comprising 2.8 million tonnes of pulp and 378 thousand tonnes of paper. Net revenue amounted to BRL 11.0 billion, while adjuste
The Estée Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN29.4.2026 23:30:00 EEST | Press release
The Estée Lauder Companies Inc. (NYSE:EL) today announced a minority investment in 111SKIN, a luxury clinical skin care brand founded by renowned plastic and reconstructive surgeon Dr. Yannis Alexandrides. Terms of the investment were not disclosed. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429495879/en/ 111SKIN's Reparative Collection Founded in 2012, 111SKIN was originally developed by Dr. Alexandrides to accelerate his patients’ healing time following procedures. At the heart of the brand is its innovative NAC Y2™, a pioneering complex designed to support skin repair and maintain a healthy, radiant and resilient complexion. Building on the foundation of this clinical expertise, 111SKIN has developed a portfolio of more than 30 products, anchored by its Black Diamond and Reparative collections and priced from $50 to $1,000. “Skin care is entering a new phase, shaped by the convergence of procedures, longevity and b
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom